ARTICLE | Clinical News
FDA panel to discuss Pfizer's Xeljanz for UC
January 26, 2018 8:17 AM UTC
FDA's Gastrointestinal Drugs Advisory Committee will meet on March 8 to discuss an sNDA from Pfizer Inc. (NYSE:PFE) for Xeljanz tofacitinib tablets to treat adults with moderate to severe active ulcerative colitis...
BCIQ Company Profiles